Search research articles
Contact Us
Filters
Showing results (271-280 of 309) with videos related to
Page
of 31
Sort By:
Scientific Reports
|
July 28, 2017
The anti-cancer effects of itraconazole in epithelial ovarian cancer
Chel Hun Choi, Ji-Yoon Ryu, Young-Jae Cho, et al.
Cancers
|
July 29, 2025
Efficacy and Safety of Chemotherapy Combined with Hormonal Therapy in Heavily Pretreated Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ELSA/KGOG3049): A Multicenter Pilot Study
Kidong Kim, Chel Hun Choi, Sang-Yoon Park, et al.
Gynecologic Oncology
|
January 21, 2024
Durvalumab with or without tremelimumab plus chemotherapy in HRR non-mutated, platinum-resistant ovarian cancer (KGOG 3045): A phase II umbrella trial
Se Ik Kim, Je-Gun Joung, Yoo-Na Kim, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics
|
April 29, 2024
Prognostic impact of erythropoietin-stimulating agent use during front-line chemotherapy in patients with ovarian cancer: A Korean multicenter cohort study
Seung-Hyuk Shim, Eun-Jung Yang, Eun Bi Jang, et al.
Cancer Genetics
|
June 4, 2013
Integrative analysis of copy number alteration and gene expression profiling in ovarian clear cell adenocarcinoma
Chang Ohk Sung, Chel Hun Choi, Young-Hyeh Ko, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 6, 2012
High galectin-1 expression correlates with poor prognosis and is involved in epithelial ovarian cancer proliferation and invasion
Ha-Jeong Kim, Hye-Kyung Jeon, Young Jae Cho, et al.
Human Pathology
|
September 4, 2012
Galectin 1 expression is associated with tumor invasion and metastasis in stage IB to IIA cervical cancer
Ha-Jeong Kim, In-Gu Do, Hye-Kyung Jeon, et al.
Journal of Clinical Medicine
|
January 18, 2020
Phase I Study of a B Cell-Based and Monocyte-Based Immunotherapeutic Vaccine, BVAC-C in Human Papillomavirus Type 16- or 18-Positive Recurrent Cervical Cancer
Chel Hun Choi, Hyun Jin Choi, Jeong-Won Lee, et al.
The Journal of Obstetrics and Gynaecology Research
|
October 29, 2021
Comparative performance of various human papillomavirus assays available in Korea for detecting cervical intraepithelial neoplasia
Yung-Taek Ouh, Ji Jeong Park, Minjoo Kang, et al.
Future Oncology (London, England)
|
May 5, 2025
DOMENICA: dostarlimab versus chemotherapy alone in first-line MMR-deficient advanced endometrial cancer patients
François Cherifi, Isabelle Ray-Coquard, Maria Jesus Rubio, et al.
Page
of 31
Search research articles
Search
Showing results (271-280 of 309) with videos related to
Sort By:
Page
of 31
Scientific Reports
|
July 28, 2017
The anti-cancer effects of itraconazole in epithelial ovarian cancer
Chel Hun Choi, Ji-Yoon Ryu, Young-Jae Cho, et al.
Cancers
|
July 29, 2025
Efficacy and Safety of Chemotherapy Combined with Hormonal Therapy in Heavily Pretreated Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ELSA/KGOG3049): A Multicenter Pilot Study
Kidong Kim, Chel Hun Choi, Sang-Yoon Park, et al.
Gynecologic Oncology
|
January 21, 2024
Durvalumab with or without tremelimumab plus chemotherapy in HRR non-mutated, platinum-resistant ovarian cancer (KGOG 3045): A phase II umbrella trial
Se Ik Kim, Je-Gun Joung, Yoo-Na Kim, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics
|
April 29, 2024
Prognostic impact of erythropoietin-stimulating agent use during front-line chemotherapy in patients with ovarian cancer: A Korean multicenter cohort study
Seung-Hyuk Shim, Eun-Jung Yang, Eun Bi Jang, et al.
Cancer Genetics
|
June 4, 2013
Integrative analysis of copy number alteration and gene expression profiling in ovarian clear cell adenocarcinoma
Chang Ohk Sung, Chel Hun Choi, Young-Hyeh Ko, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 6, 2012
High galectin-1 expression correlates with poor prognosis and is involved in epithelial ovarian cancer proliferation and invasion
Ha-Jeong Kim, Hye-Kyung Jeon, Young Jae Cho, et al.
Human Pathology
|
September 4, 2012
Galectin 1 expression is associated with tumor invasion and metastasis in stage IB to IIA cervical cancer
Ha-Jeong Kim, In-Gu Do, Hye-Kyung Jeon, et al.
Journal of Clinical Medicine
|
January 18, 2020
Phase I Study of a B Cell-Based and Monocyte-Based Immunotherapeutic Vaccine, BVAC-C in Human Papillomavirus Type 16- or 18-Positive Recurrent Cervical Cancer
Chel Hun Choi, Hyun Jin Choi, Jeong-Won Lee, et al.
The Journal of Obstetrics and Gynaecology Research
|
October 29, 2021
Comparative performance of various human papillomavirus assays available in Korea for detecting cervical intraepithelial neoplasia
Yung-Taek Ouh, Ji Jeong Park, Minjoo Kang, et al.
Future Oncology (London, England)
|
May 5, 2025
DOMENICA: dostarlimab versus chemotherapy alone in first-line MMR-deficient advanced endometrial cancer patients
François Cherifi, Isabelle Ray-Coquard, Maria Jesus Rubio, et al.
Page
of 31